|Conditional recommendation based on very-low-quality evidence; may consider starting an OSM (specifically apremilast) if the patient has recurrent infections.| |
|In adult patients with active PsA and predominant enthesitis despite treatment with OSM,| |
|8. Switch to a TNFi biologic over an IL-17i biologic (PICO 53)|Low (72, 73, 76, 89, 90, 92)|